Riphah International University
riphah.edu.pkTotal trials
2,011
Active
473
Phase 3
0
Total enrollment
106,384
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Intralesional Acyclovir | — | — | — | — | — | 1 | |
| Intralesional Vitamin D3 | — | — | — | — | — | 1 | |
| Moderate-Intensity continuous training | — | — | — | — | — | 1 |
Next readouts
- 2024-12-30
- 2026-05-20
Top conditions
- Stroke129
- Sports Physical Therapy98
- Cerebral Palsy66
- Neck Pain63
- Low Back Pain59
- Knee Osteoarthritis56
- Down Syndrome38
- Adhesive Capsulitis28
Frequently asked questions about Riphah International University
- How many clinical trials does Riphah International University have on ClinicalTrials.gov?
- Riphah International University is listed as the lead sponsor on 2,011 clinical trials in ClinicalTrials.gov, 473 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Riphah International University's trials are in Phase 3?
- 0 of Riphah International University's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Riphah International University focus on?
- Riphah International University's most-studied conditions on ClinicalTrials.gov are Stroke, Sports Physical Therapy, Cerebral Palsy, Neck Pain, Low Back Pain.
- When are Riphah International University's next clinical trial readouts?
- Riphah International University has 2 upcoming primary-completion readouts tracked here; the soonest is “Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients”, expected around 2024-12-30.